<bill session="116" type="h" number="2038" updated="2022-11-01T19:02:23Z">
  <state datetime="2019-04-02">REFERRED</state>
  <status>
    <introduced datetime="2019-04-02"/>
  </status>
  <introduced datetime="2019-04-02"/>
  <titles>
    <title type="display">State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019</title>
    <title type="official" as="introduced">To allow State-based, market-oriented, prescription drug negotiations to lower pharmaceutical drug prices, to encourage competition, to increase consumer choice and access, and for other purposes.</title>
    <title type="short" as="introduced">State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019</title>
  </titles>
  <sponsor bioguide_id="M001187"/>
  <cosponsors>
    <cosponsor bioguide_id="B001305" joined="2019-04-15"/>
    <cosponsor bioguide_id="L000589" joined="2019-10-17"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-02">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-04-02" state="REFERRED">
      <text>Referred to the House Committee on the Judiciary.</text>
    </action>
    <action datetime="2019-05-15">
      <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU05" name="House Judiciary" subcommittee="Administrative State, Regulatory Reform, and Antitrust" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="4796" relation="unknown"/>
    <bill session="116" type="h" number="8527" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Child health"/>
    <term name="Child safety and welfare"/>
    <term name="Congressional oversight"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health facilities and institutions"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Long-term, rehabilitative, and terminal care"/>
    <term name="Prescription drugs"/>
    <term name="Rural conditions and development"/>
    <term name="Sales and excise taxes"/>
    <term name="State and local finance"/>
  </subjects>
  <amendments/>
  <summary date="2020-12-31T17:25:27Z" status="Introduced in House">State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.</summary>
</bill>
